Cargando…

DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing

Antisense oligonucleotides (ASOs) are recognized therapeutic agents for the modulation of specific genes at the post-transcriptional level. Similar to any medical drugs, there are opportunities to improve their efficacy and safety. Here we develop a short DNA/RNA heteroduplex oligonucleotide (HDO) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishina, Kazutaka, Piao, Wenying, Yoshida-Tanaka, Kie, Sujino, Yumiko, Nishina, Tomoko, Yamamoto, Tsuyoshi, Nitta, Keiko, Yoshioka, Kotaro, Kuwahara, Hiroya, Yasuhara, Hidenori, Baba, Takeshi, Ono, Fumiko, Miyata, Kanjiro, Miyake, Koichi, Seth, Punit P., Low, Audrey, Yoshida, Masayuki, Bennett, C. Frank, Kataoka, Kazunori, Mizusawa, Hidehiro, Obika, Satoshi, Yokota, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918363/ https://www.ncbi.nlm.nih.gov/pubmed/26258894 http://dx.doi.org/10.1038/ncomms8969

Ejemplares similares

Highly efficient silencing of microRNA by heteroduplex oligonucleotides
por: Yoshioka, Kotaro, et al.
Publicado: (2019)

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol
por: Nishina, Tomoko, et al.
Publicado: (2015)

Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo
por: Kuwahara, Hiroya, et al.
Publicado: (2018)

Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route
por: Murakami, Masahiro, et al.
Publicado: (2015)

Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing
por: Asada, Ken, et al.
Publicado: (2021)

DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo
por: Ohyagi, Masaki, et al.
Publicado: (2021)

Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs
por: Hara, Rintaro Iwata, et al.
Publicado: (2018)

Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve
por: Kaburagi, Hidetoshi, et al.
Publicado: (2022)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

Separation-related rapid nuclear transport of DNA/RNA heteroduplex oligonucleotide: unveiling distinctive intracellular trafficking
por: Ono, Daisuke, et al.
Publicado: (2020)

Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo
por: Asami, Yutaro, et al.
Publicado: (2021)

DNA/RNA heteroduplex oligonucleotides: An unanticipated twist in the delivery of ASOs
por: Setten, Ryan L., et al.
Publicado: (2022)

Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol–conjugated heteroduplex oligonucleotide in mice
por: Suzuki, Motohiro, et al.
Publicado: (2021)

Evaluation of off‐target effects of gapmer antisense oligonucleotides using human cells
por: Yoshida, Tokuyuki, et al.
Publicado: (2019)

Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells
por: Sousa de Almeida, Mauro, et al.
Publicado: (2022)

Change of intracellular calcium level causes acute neurotoxicity by antisense oligonucleotides via CSF route
por: Jia, Chunyan, et al.
Publicado: (2022)

Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice
por: Machida, Akira, et al.
Publicado: (2013)

Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
por: Anraku, Y., et al.
Publicado: (2017)

Nearest neighbor parameters for Watson–Crick complementary heteroduplexes formed between 2′-O-methyl RNA and RNA oligonucleotides
por: Kierzek, Elzbieta, et al.
Publicado: (2006)

A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma
por: Chu, Zhenzhen, et al.
Publicado: (2023)

Effects of combinations of gapmer antisense oligonucleotides on the target reduction
por: Yanagidaira, Mitsugu, et al.
Publicado: (2023)

Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies
por: Zeniya, Satoshi, et al.
Publicado: (2022)

Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme
por: Yui, Daishi, et al.
Publicado: (2015)

Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides
por: Yoshida, Tokuyuki, et al.
Publicado: (2022)

Conjugation of oligonucleotides with activated carbamate reagents prepared by the Ugi reaction for oligonucleotide library synthesis
por: Kita, Ryosuke, et al.
Publicado: (2022)

Single-stranded heteroduplex intermediates in λ Red homologous recombination
por: Maresca, Marcello, et al.
Publicado: (2010)

Kinetics of heterochiral strand displacement from PNA–DNA heteroduplexes
por: Kundu, Nandini, et al.
Publicado: (2021)

Superior Silencing by 2′,4′-BNA(NC)-Based Short Antisense Oligonucleotides Compared to 2′,4′-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2012)

Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs
por: Takakusa, Hideo, et al.
Publicado: (2023)

Structural basis for the recognition of guide RNA and target DNA heteroduplex by Argonaute
por: Miyoshi, Tomohiro, et al.
Publicado: (2016)

The detection of subtle differences between different orthopoxvirus genomes by heteroduplex analysis
por: Kinchington, Derek, et al.
Publicado: (1984)

Karnovsky’s fixative prevents artifacts appearing as vacuolation derived from tissue processing in kidneys treated with antisense oligonucleotide
por: Nishina, Hironobu, et al.
Publicado: (2021)

Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro
por: Shimo, Takenori, et al.
Publicado: (2014)

An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells
por: Yoshida, Misa, et al.
Publicado: (2023)

Optical coherence tomography and video recording of a case of bilateral contractile peripapillary staphyloma
por: Yoshida, Tomoyo, et al.
Publicado: (2018)

Is TEVAR with Full Petticoat Technique Effective for Complicated Acute Type B Dissection Cases?
por: Nishina, Takeshi, et al.
Publicado: (2018)

Early experience with a new integrated microwave surgical device, Acrosurg Revo®, for laparoscopic surgery: A case series of two patients
por: Terada, Yoshitaka, et al.
Publicado: (2020)

Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durvalumab in Japanese patients with advanced solid malignancies: a phase 1 study
por: Nishina, Tomohiro, et al.
Publicado: (2022)

Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
por: Min, Hyun Su, et al.
Publicado: (2020)

Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
por: Tomiyama, Yasuyuki, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hr1m0oep2isp3ulfk332glf1jk